Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables Refunds
Ratios

OptimizeRx (OPRX) Leases (2019 - 2025)

OptimizeRx's Leases history spans 7 years, with the latest figure at $481000.0 for Q3 2025.

  • For Q3 2025, Leases rose 13.98% year-over-year to $481000.0; the TTM value through Sep 2025 reached $481000.0, up 13.98%, while the annual FY2024 figure was $366000.0, 36.13% down from the prior year.
  • Leases for Q3 2025 was $481000.0 at OptimizeRx, down from $528000.0 in the prior quarter.
  • Across five years, Leases topped out at $10.5 million in Q1 2022 and bottomed at $14544.0 in Q2 2023.
  • The 5-year median for Leases is $366000.0 (2024), against an average of $888018.4.
  • The largest annual shift saw Leases plummeted 97.98% in 2023 before it surged 3145.32% in 2024.
  • A 5-year view of Leases shows it stood at $328820.0 in 2021, then decreased by 28.44% to $235320.0 in 2022, then soared by 143.5% to $573000.0 in 2023, then plummeted by 36.13% to $366000.0 in 2024, then surged by 31.42% to $481000.0 in 2025.
  • Per Business Quant, the three most recent readings for OPRX's Leases are $481000.0 (Q3 2025), $528000.0 (Q2 2025), and $303000.0 (Q1 2025).